| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0304-3835(01)00857-6 |
| P698 | PubMed publication ID | 11880185 |
| P2093 | author name string | Thomas Rutherford | |
| Tatsuo Yamamoto | |||
| Zhaocong Chen | |||
| Kaori Ohtani | |||
| Frederick Naftolin | |||
| Kazuo Satoh | |||
| Hideki Sakamoto | |||
| Atushi Kikuchi | |||
| P2860 | cites work | The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients | Q28235260 |
| cDNA cloning and sequencing of the protein-tyrosine kinase substrate, ezrin, reveals homology to band 4.1 | Q28261183 | ||
| Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors | Q28510087 | ||
| The ezrin protein family: membrane-cytoskeleton interactions and disease associations | Q30428648 | ||
| Regulation of cortical structure by the ezrin-radixin-moesin protein family | Q33536481 | ||
| Rapid phosphorylation and reorganization of ezrin and spectrin accompany morphological changes induced in A-431 cells by epidermal growth factor | Q36219929 | ||
| Ezrin, a membrane-cytoskeletal linking protein, is involved in the process of invasion of endometrial cancer cells | Q40902115 | ||
| Hormones and cancer in humans | Q40933377 | ||
| Induction of tyrosine phosphorylation and translocation of ezrin by hepatocyte growth factor/scatter factor. | Q41257814 | ||
| Ezrin has a COOH-terminal actin-binding site that is conserved in the ezrin protein family | Q42720142 | ||
| Moesin and CD44 expression in cutaneous melanocytic tumours | Q47833787 | ||
| Mr 75,000 protein, a tumor marker in renal adenocarcinoma, reacting with antibodies to a synthetic peptide based on a cloned human endogenous retroviral nucleotide sequence | Q70096841 | ||
| High levels of ezrin expressed by human pancreatic adenocarcinoma cell lines with high metastatic potential | Q77754238 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adenocarcinoma | Q356033 |
| endometrial hyperplasia | Q686574 | ||
| P304 | page(s) | 79-86 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | Cancer Letters | Q326372 |
| P1476 | title | Ezrin, a membrane-cytoskeletal linking protein, is highly expressed in atypical endometrial hyperplasia and uterine endometrioid adenocarcinoma | |
| P478 | volume | 179 |
| Q35615528 | 12-O-Tetradecanoylphorbol-13-Acetate Induces Up-Regulated Transcription of Variant 1 but Not Variant 2 of VIL2 in Esophageal Squamous Cell Carcinoma Cells via ERK1/2/AP-1/Sp1 Signaling |
| Q42090058 | Association of ezrin expression in intestinal and diffuse gastric carcinoma with clinicopathological parameters and tumor type |
| Q34137969 | Claudin7 and moesin in endometrial Adenocarcinoma; a retrospective study of 265 patients |
| Q46483696 | Decreased ezrin and paxillin expression in human urothelial bladder tumors correlate with tumor progression |
| Q34539747 | Differential tissue and subcellular expressionof ERM proteins in normal and malignant tissues: cytoplasmic ezrin expression has prognostic significance for head and neck squamous cell carcinoma |
| Q39359766 | Expression of ezrin correlates with malignant phenotype of lung cancer, and in vitro knockdown of ezrin reverses the aggressive biological behavior of lung cancer cells |
| Q35681855 | Expression of ezrin in human embryonic, fetal, and normal adult tissues |
| Q47932092 | Expression of ezrin in prostatic intraepithelial neoplasia |
| Q33482513 | Expression of ezrin is associated with invasion and dedifferentiation of hepatitis B related hepatocellular carcinoma |
| Q40157152 | Expression of the cytoskeleton linker protein ezrin in human cancers |
| Q83781974 | Ezrin expression as a prognostic marker in colorectal adenocarcinoma |
| Q82917831 | Ezrin expression is related to poor prognosis in FIGO stage I endometrioid carcinomas |
| Q73739370 | Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients |
| Q80844578 | Ezrin in primary cutaneous melanoma |
| Q39525953 | Ezrin is key regulator of Src-induced malignant phenotype in three-dimensional environment |
| Q34187445 | Ezrin phosphorylation on tyrosine 477 regulates invasion and metastasis of breast cancer cells |
| Q38935906 | Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas |
| Q34779117 | Gene expression analysis of early stage endometrial cancers reveals unique transcripts associated with grade and histology but not depth of invasion |
| Q34713009 | Gene expression profiles in stage I uterine serous carcinoma in comparison to grade 3 and grade 1 stage I endometrioid adenocarcinoma |
| Q53086422 | Increase in ezrin expression from benign to malignant breast tumours. |
| Q36831462 | Molecular determinants of invasion in endometrial cancer. |
| Q34774429 | NGX6a is degraded through a proteasome-dependent pathway without ubiquitination mediated by ezrin, a cytoskeleton-membrane linker |
| Q64076170 | Neutrophil Cell Shape Change: Mechanism and Signalling during Cell Spreading and Phagocytosis |
| Q83939905 | Phosphorylated ezrin is located in the nucleus of the osteosarcoma cell |
| Q24337035 | Plasmodium vivax inhibits erythroid cell growth through altered phosphorylation of the cytoskeletal protein ezrin |
| Q40616652 | Potent phagocytic activity discriminates metastatic and primary human malignant melanomas: a key role of ezrin |
| Q37294930 | Raf-1 levels determine the migration rate of primary endometrial stromal cells of patients with endometriosis |
| Q38552469 | Scaffolding during the cell cycle by A-kinase anchoring proteins. |
| Q37134443 | Sp1 and AP-1 regulate expression of the human gene VIL2 in esophageal carcinoma cells |
| Q42860390 | The cytoskeletal protein ezrin regulates EC proliferation and angiogenesis via TNF-alpha-induced transcriptional repression of cyclin A. |
| Q40602468 | The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis |
| Q28199313 | The role of the CD44/ezrin complex in cancer metastasis |
| Q39904552 | The role of the membrane cytoskeleton cross-linker ezrin in medulloblastoma cells |
| Q36179753 | Upregulated expression of Ezrin and invasive phenotype in malignantly transformed esophageal epithelial cells |
| Q35005380 | ß1 integrin binding phosphorylates ezrin at T567 to activate a lipid raft signalsome driving invadopodia activity and invasion |
Search more.